Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I NI-0101 single-dose IV study in healthy volunteers with or without LPS challenge
NL-OMON37163Phase 1Active, not recruiting
- Sponsor
- Lightchain Bioscience
- Start
- Nov 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in rheumatoid arthritis (RA) comparing NI-0101 with Placebo (2 arms). Started Nov 2012; status: active, not recruiting.
02
Drugs
paridiprubart
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON37163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37163.